Patents by Inventor Daniel M. Green

Daniel M. Green has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7531542
    Abstract: The present invention relates to Gonadotropin Releasing Hormone (GnRH, also known as Luteinizing Hormone Releasing Hormone) receptor antagonists.
    Type: Grant
    Filed: May 9, 2006
    Date of Patent: May 12, 2009
    Assignee: Wyeth
    Inventors: Daniel M. Green, Diane B. Hauze, Charles W. Mann, Jeffrey C. Pelletier, Matthew D. Vera
  • Publication number: 20040196365
    Abstract: The invention provides an automated microscope system, a computer program product which may be programmed into the automated microscope system and a method for acquiring images at substantially the maximum acquisition rate of a camera while and as devices external to the camera, which vary various parameters of the acquired images, operate asynchronously with the camera so as to allow the acquired images to be displayed as a sequence that shows continuous variation in the acquisition parameters.
    Type: Application
    Filed: April 19, 2004
    Publication date: October 7, 2004
    Inventors: Daniel M. Green, William Peterson, Avrum Cohen, Michael D. Sjaastad, Jeffrey A. Stuckey
  • Patent number: 6724419
    Abstract: The invention provides an automated microscope system, a computer program product in a computer readable medium and a method for acquiring images at substantially the maximum acquisition rate of a camera while and as devices external to the camera, which vary various parameters of the acquired images, operate asynchronously with the camera so as to allow the acquired images to be displayed as a sequence that shows continuous variation in the acquisition parameters.
    Type: Grant
    Filed: August 14, 2000
    Date of Patent: April 20, 2004
    Assignee: Universal Imaging Corporation
    Inventors: Daniel M. Green, William Peterson, Avrum Cohen, Michael D. Sjaastad, Jeffrey A. Stuckey
  • Patent number: 6602864
    Abstract: The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, which are for treating a patient suffering from, or subject to, physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.
    Type: Grant
    Filed: June 3, 1998
    Date of Patent: August 5, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Yong Mi Choi-Sledeski, Henry W. Pauls, Jeffrey N. Barton, William R. Ewing, Daniel M. Green, Michael R. Becker, Yong Gong
  • Publication number: 20020111369
    Abstract: This invention provides compounds of formula I having the structure 1
    Type: Application
    Filed: January 10, 2002
    Publication date: August 15, 2002
    Applicant: American Home Products Corporation
    Inventors: Jay E. Wrobel, John F. Rogers, Daniel M. Green, Wenling Kao, James W. Jetter
  • Patent number: 6355633
    Abstract: This invention provides compounds of formula I having the structure wherein R1, Ar, Ar′, and Q are as defined in the specification, or a pharmaceutically acceptable salt thereof, which are useful as contraceptive agents.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: March 12, 2002
    Assignee: American Home Products Corporation
    Inventors: Jay E. Wrobel, John F. Rogers, Daniel M. Green, Wenling Kao, James W. Jetter
  • Publication number: 20020013310
    Abstract: The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, for treating a patient suffering from, or subject to, a physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.
    Type: Application
    Filed: July 30, 2001
    Publication date: January 31, 2002
    Inventors: Yong Mi Choi-Sledeski, Heinz W. Pauls, Jeffrey N. Barton, William R. Ewing, Daniel M. Green, Michael R. Becker, Yong Gong, Julian Levell
  • Patent number: 6281227
    Abstract: The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, for treating a patient suffering from, or subject to, a physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.
    Type: Grant
    Filed: December 2, 1999
    Date of Patent: August 28, 2001
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Yong Mi Choi-Sledeski, Heinz W. Pauls, Jeffrey N. Barton, William R. Ewing, Daniel M. Green, Michael R. Becker, Yong Gong, Julian Levell